Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma

Pediatric Research

Volumn 43, Issue 1, 1998, Pages 139-144

  Iolascon, Achille ^a   Giordani, Lucia ^a   Moretti, Arcangela ^a   Tonini, Gian Paolo ^c   Lo Cunsolo, Crocefissa ^c   Mastropietro, Silvia ^b   Borriello, Adriana ^b   Della Ragione, Fulvio ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR;

ARTICLE; CANCER STAGING; CELL DIVISION; DNA REPAIR; ENZYME INHIBITION; EXON; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; METHYLATION; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN FAMILY; TRANSCRIPTION REGULATION;

EID: 0031893819     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199801000-00021     Document Type: Article

References (37)

1. Pines J 1995 Cyclins, CDKs and cancer. Semin Cancer Biol 6:63-72
2. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, Van der Riet P, Blaugrund JE, Sidransky D 1994 Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-417
3. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D, Sidransky D 1995 Frequency of homozygous deletion at p16/CDKN2 in primary tumors. Nat Genet 11:210-212
4. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE, Skolnick MH 1994 A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440
5. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA 1994 Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756
6. INK4A in human cancer. Proc Natl Acad Sci USA 91:11045-11049
7. INK4B/MTS2 and p18 genes in primary and metastatic lung cancer. Cancer Res 55:1448-1451
8. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M 1995 Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytoma. Cancer Res 55:20-25
9. Takeushi S, Bartram CR, Seriu T, Miller CW, Tobler A, Janssen WG, Reiter A, Ludwig WD, Zimmermann M, Schwaller J, Lee E, Miyoshi, Koeffler HP 1995 Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 66:755-760
10. Iolascon A, Faienza MF, Della Ragione F, Coppola B, Rosolen A, Basso G, Schettini F 1996 Analysis of Cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B and CDKN2C) in childhood rhabdomyosarcoma. Genes Chromosomes Cancer 15:217-222
11. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8:2939-2945
12. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257-261
13. Hirai H, Roussel MF, Kato, J-Y, Ashmun RA, Sherr, CJ 1995 Novel INK4 proteins, p19, p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15:2672-2681
14. INK4. Mol Cell Biol 15:2682-2688
15. INK4A and p18, in childhood T-cell lineage acute lymphoblastic leukemias. Leukemia 10:255-260
16. Hussussian CJ, Struewing JP, Goldstein AM, Higgings PAT, Ally DS, Sheahan MD, Clark Jr WH, Tucker MA, Dracopoli NC 1995 Germline p16 mutations in familial melanoma. Nat Genet 8:15-21
17. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y 1994 Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54:3396-3397
18. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinsten CL, Hruban RH, Yeo CJ, Kern SE 1994 Frequent somatic mutations and homozygous deletions of p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8:27-32
19. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D 1995 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686-692
20. Gonzales-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA 1995 Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human correlates with gene silencing. Cancer Res 55:4531-4535
21. INK4BI Cancer Res 56:722-727
22. Takita J, Hayashi Y, Kohno T, Shiseki M, Yamaguchi N, Hanada R, Yamamoto K, Yokota J 1995 Allelotype of neuroblastoma. Oncogene 11:1829-1834
23. Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM, Magdelenat H, Thomas G, Delattre O 1994 Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer 10:275-281
24. Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M 1994 There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes Cancer 10:30-39
25. Evans AE, D'Angio DJ, Randolph J 1971 A proposed staging for children with neuroblastoma. Cancer 27:374-378
26. Maniatis T, Fritsch E, Sambrook J 1990 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 9.16-9.23, 7.6-7.22
27. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B 1994 Deletion of p16 and p15 genes in brain tumors. Cancer Res 54:6353-6358
28. Serra A, Gottardi E, Della Ragione F, Saglio G, Iolascon A 1995 Involvement of the cyclin-dependent kinase 4 inhibitor (CDK4I) gene in the pathogenesis of lymphoid blast crisis of chronic myelogeneous leukemia. Br J Haematol 91:625-629
29. Iolascon A, Parrella T, Perrotta S, Guardamagna O, Coates PM, Sartore M, Surrey S, P Fortina 1994 Rapid detection of medium-chain acyl-CoA Dehydrogenase gene mutations by non-radioactive, single-strand conformation polymorphism minigels. J Med Genet 31:551-554
30. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
31. Lois AF, Cooper LT, Geng YG, Nobori T, Carson D 1995 Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Cancer Res 55:4010-4013
32. Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE, Brodeur GM 1989 Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastoma: correlation with N-myc amplification. Proc Natl Acad Sci USA 86:3753-3757
33. Kurahashi H, Oue T, Akagi K, Fukuzawa M, Okada A, Tawa, A 1995 Allelic status on 1p and 11p15 in neuroblatoma and benign ganglioneuroma. Int J Oncol 6:669-674
34. Beltinger CP, White PS, Sulman EP, Maris JM, Brodeur, GM 1995 No CDKN2 mutations in neuroblastomas. Cancer Res 55:2053-2055
35. Kawamata N, Seriu T, Koeffler PH, Bartram CR 1996 Molecular analysis of the cyclin-dependent kinase inhibitor family: p16 (CDKN2/MTS1/INK4A), p18 (INK4C) and p27(Kip1) genes in neuroblastoma. Cancer 77:570-575
36. Diccianni MB, Chiau LS, Batova A, Vu TQ, Yu AL 1996 The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance. Cancer Lett 104:183-192
37. Neville EM, Stewart M, Myskow M, Donnelly RJ, Field JK 1995 Loss of heterozygosisty at 9p23 defines a novel locus in non-small lung cancer. Oncogene 11:581-585